ITRACONAZOLE 130 MG WITH SUPRA BIOAVALIABLE TECHNOLOGY CAP
FUNGASOL SB 130 is a drink that consists of Itraconazole of 130 mg with supra bioavailable technology that enhances absorption and action of the medication. It is an antifungal drug utilized in the treatment of a large variety of fungal infections. It operates by preventing the development of fungi and eradicating the infection. It is also popularly applied in treating fungal infection of skin like ringworm, athlete foot, jock itch and fungus of the nails. It can also be used to cure fungal infections in the mouth, the throat, lungs among other body parts. This is a high order formulation that makes it better absorbed and responds to treatment quicker.
FUNGASOL SB 130 is a drink that consists of Itraconazole of 130 mg with supra bioavailable technology that enhances absorption and action of the medication. It is an antifungal drug utilized in the treatment of a large variety of fungal infections. It operates by preventing the development of fungi and eradicating the infection. It is also popularly applied in treating fungal infection of skin like ringworm, athlete foot, jock itch and fungus of the nails. It can also be used to cure fungal infections in the mouth, the throat, lungs among other body parts. This is a high order formulation that makes it better absorbed and responds to treatment quicker.
Q1. What is FUNGASOL SB 130 used for?
A: It is administered to address fungal infections of the skin, nails and other body parts.
Q2. But what is supra bioavailable technology?
A: It enhances uptake of itraconazole, hence increasing the effectiveness of the medicine.
Q3. Does FUNGASOL SB 130 work in fungal skin infection?
A: Yes, it is very effective in the treatment of the ringworm, foot athlete, and other fungal infections.
Q4. How should I take FUNGASOL SB 130?
A: Take it, as advised by your doctor, preferably after food.
Q5. Will FUNGASOL SB 130 have an impact on the liver?
A: It can very rarely impact on liver function and hence it may have to be monitored.